- Preview Available
- Scholarly Journal
Propensity score analysis of high-dose rate brachytherapy, immune checkpoint inhibitors, and docetaxel in second-line advanced NSCLC treatment
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 12650.
DOI:10.1038/s41598-025-97918-z
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.